Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sclerotherapy for hydroceles and spermatoceles with 99.5% ethanol (dose escalation, phase 2)
2020-004630-38Phase 2Completed
- Sponsor
- Region Jämtland Härjedalen
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ethanol in hydrocele, spermatocele and Epididymal Cyst (2 arms), sponsored by Region Jämtland Härjedalen. Primary endpoints: Systemic ethanol absorption and Cure rate. Started Oct 2020; status: completed.
02
Drugs
ethanol
03
Conditions
hydrocelespermatoceleEpididymal Cyst
Beyond the preview
Go deeper on 2020-004630-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004630-38.